Mia Gonzales, MD
Pulmonary Disease · Greenville, NCNPI 1598292674
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Abiomed at 34.9% of the total. Reporting peaked in 2023 at $241 and has fallen 79.0% since, to $50 in 2025. That places this record below the midpoint for pulmonary disease clinicians in NC, where the typical reported total is $1,396.
Across 14 payments — averaging $27.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$133
- Resmed Corp$50
- La Jolla Pharmaceutical Company$44
- Janssen Scientific Affairs, LLC$36
- Amgen$19
- Merck$18
- plus $81 from 5 others
What the payments were for
- Food & beverage$382100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 1 | $133 |
| Resmed Corp | 2 | $50 |
| La Jolla Pharmaceutical Company | 3 | $44 |
| Janssen Scientific Affairs, LLC | 1 | $36 |
| Amgen | 1 | $19 |
| Merck | 1 | $18 |
| Shionogi Inc | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| GSK | 1 | $17 |
| Nxstage Medical, Inc. | 1 | $15 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$133
How this compares
$382 in reported general payments places this provider in the 30th percentile of 393 pulmonary disease providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Greenville
- Ogugua ObiGreenville$16K
- Michael PritchettPinehurst$1.3M
- Michael WertGreensboro$412K
- Eugene BleeckerWinston Salem$357K
- Bradley IcardPinehurst$299K
- James DonohueChapel Hill$271K
- Eric MeltzerDurham$262K
- Daniel BreaultWilmington$257K
- Scott SkiboPinehurst$229K
- Jill OharWinston Salem$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.